首页> 外国专利> CANCER PROGRESSION RISK ASSESSMENT BY MICROVASCULAR PHENOTYPE

CANCER PROGRESSION RISK ASSESSMENT BY MICROVASCULAR PHENOTYPE

机译:微血管表型的癌症进展风险评估

摘要

Repression of CD36 vasculature in stromal tissues surrounding a precancerous lesion provides is indicative of increased risk of subsequent progression to invasive cancer. Methods of assessing progression risk by measuring the abundance of CD36 vasculature in stromal tissues surrounding a precancerous lesion are provided, useful for various cancer types, including for assessing the risk of DCIS progression to breast cancer. Immunohistochemical analysis methods and diagnostic thresholds are provided, as well as associated methods of treatment and diagnostic kits.
机译:癌前病变周围基质组织中CD36脉管系统的抑制指示随后发展为浸润性癌症的风险增加。提供了通过测量癌前病变周围基质组织中CD36脉管系统的丰度来评估进展风险的方法,可用于多种癌症类型,包括评估DCIS演变为乳腺癌的风险。提供了免疫组织化学分析方法和诊断阈值,以及相关的治疗方法和诊断试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号